Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Methods for Building and Validating Equations for Physiology-Based Mathematical Models: Glucose Metabolism and Type 2 Diabetes in the Archimedes Model.

Eddy DM, Schlessinger L.

Med Decis Making. 2016 Apr;36(3):410-21. doi: 10.1177/0272989X15601864. Epub 2015 Oct 7.

PMID:
26446913
2.

Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.

Jaime Caro J, Eddy DM, Kan H, Kaltz C, Patel B, Eldessouki R, Briggs AH; ISPOR-AMCP-NPC Modeling CER Task Forces.

Value Health. 2014 Mar;17(2):174-82. doi: 10.1016/j.jval.2014.01.003. Erratum in: Value Health. 2016 Jan;19(1):121.

3.

ISPOR-SMDM task force's recommendations for good modeling practices-reply to letter to the editor by Corro Ramos.

Caro JJ, Eddy DM, Hollingworth W, Tsevat J, McDonald KM, Wong JB, Briggs AH, Siebert U, Kuntz KM.

Value Health. 2013 Sep-Oct;16(6):1108. doi: 10.1016/j.jval.2013.06.016. No abstract available.

4.

The 'Global Outcomes Score': a quality measure, based on health outcomes, that compares current care to a target level of care.

Eddy DM, Adler J, Morris M.

Health Aff (Millwood). 2012 Nov;31(11):2441-50. doi: 10.1377/hlthaff.2011.1274.

PMID:
23129674
5.

A simulation shows limited savings from meeting quality targets under the Medicare Shared Savings Program.

Eddy DM, Shah R.

Health Aff (Millwood). 2012 Nov;31(11):2554-62. doi: 10.1377/hlthaff.2012.0385. Epub 2012 Oct 3.

PMID:
23035036
6.

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.

Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB; ISPOR−SMDM Modeling Good Research Practices Task Force.

Value Health. 2012 Sep-Oct;15(6):843-50. doi: 10.1016/j.jval.2012.04.012.

7.

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.

Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB; ISPOR-SMDM Modeling Good Research Practices Task Force.

Med Decis Making. 2012 Sep-Oct;32(5):733-43.

PMID:
22990088
8.

Individualized guidelines: the potential for increasing quality and reducing costs.

Eddy DM, Adler J, Patterson B, Lucas D, Smith KA, Morris M.

Ann Intern Med. 2011 May 3;154(9):627-34. doi: 10.7326/0003-4819-154-9-201105030-00008.

PMID:
21536939
9.

The origins of evidence-based medicine--a personal perspective.

Eddy DM.

Virtual Mentor. 2011 Jan 1;13(1):55-60. doi: 10.1001/virtualmentor.2011.13.1.mhst1-1101. No abstract available.

10.

Effect of smoking cessation advice on cardiovascular disease.

Eddy DM, Peskin B, Shcheprov A, Pawlson G, Shih S, Schaaf D.

Am J Med Qual. 2009 May-Jun;24(3):241-9. doi: 10.1177/1062860609332509. Epub 2009 Mar 30.

PMID:
19332865
11.

The potential effects of HEDIS performance measures on the quality of care.

Eddy DM, Pawlson LG, Schaaf D, Peskin B, Shcheprov A, Dziuba J, Bowman J, Eng B.

Health Aff (Millwood). 2008 Sep-Oct;27(5):1429-41. doi: 10.1377/hlthaff.27.5.1429.

PMID:
18780934
12.

The metabolic syndrome and cardiovascular risk: implications for clinical practice.

Eddy DM, Schlessinger L, Heikes K.

Int J Obes (Lond). 2008 May;32 Suppl 2:S5-10. doi: 10.1038/ijo.2008.28. Review.

PMID:
18469838
13.

Diabetes Risk Calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes.

Heikes KE, Eddy DM, Arondekar B, Schlessinger L.

Diabetes Care. 2008 May;31(5):1040-5. Epub 2007 Dec 10.

PMID:
18070993
14.

Linking electronic medical records to large-scale simulation models: can we put rapid learning on turbo?

Eddy DM.

Health Aff (Millwood). 2007 Mar-Apr;26(2):w125-36. Epub 2007 Jan 26. Review.

PMID:
17259194
15.
16.

Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

Eddy DM, Schlessinger L, Kahn R.

Ann Intern Med. 2005 Aug 16;143(4):251-64.

PMID:
16103469
17.

Evidence-based medicine: a unified approach.

Eddy DM.

Health Aff (Millwood). 2005 Jan-Feb;24(1):9-17.

PMID:
15647211
18.

Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.

Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH.

Behav Brain Res. 2004 Aug 31;153(2):507-19.

PMID:
15265649
19.

Paying for performance: Medicare should lead.

Berwick DM, DeParle NA, Eddy DM, Ellwood PM, Enthoven AC, Halvorson GC, Kizer KW, McGlynn EA, Reinhardt UE, Reischauer RD, Roper WL, Rowe JW, Schaeffer LD, Wennberg JE, Wilensky GR.

Health Aff (Millwood). 2003 Nov-Dec;22(6):8-10. No abstract available.

PMID:
14649428
20.

Validation of the archimedes diabetes model.

Eddy DM, Schlessinger L.

Diabetes Care. 2003 Nov;26(11):3102-10.

PMID:
14578246
21.

Archimedes: a trial-validated model of diabetes.

Eddy DM, Schlessinger L.

Diabetes Care. 2003 Nov;26(11):3093-101.

PMID:
14578245
22.

Archimedes: a new model for simulating health care systems--the mathematical formulation.

Schlessinger L, Eddy DM.

J Biomed Inform. 2002 Feb;35(1):37-50.

23.

The use of evidence and cost effectiveness by the courts: how can it help improve health care?

Eddy DM.

J Health Polit Policy Law. 2001 Apr;26(2):387-408. No abstract available.

PMID:
11330086
24.

Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Quality Assurance.

Schneider EC, Riehl V, Courte-Wienecke S, Eddy DM, Sennett C.

JAMA. 1999 Sep 22-29;282(12):1184-90.

PMID:
10501126
25.

Who should determine when health care is medically necessary?

Eddy DM.

N Engl J Med. 1999 Jul 1;341(1):59; author reply 60. No abstract available.

PMID:
10391767
26.

Performance measurement: problems and solutions.

Eddy DM.

Health Aff (Millwood). 1998 Jul-Aug;17(4):7-25.

PMID:
9691542
27.

Breast cancer screening in women younger than 50 years of age: what's next?

Eddy DM.

Ann Intern Med. 1997 Dec 1;127(11):1035-6. No abstract available.

PMID:
9412286
28.

Investigational treatments. How strict should we be?

Eddy DM.

JAMA. 1997 Jul 16;278(3):179-85. No abstract available.

PMID:
9218650
29.

Balancing cost and quality in fee-for-service versus managed care.

Eddy DM.

Health Aff (Millwood). 1997 May-Jun;16(3):162-73. No abstract available.

PMID:
9141333
30.

What defines a good doctor is about to change. Interview by Ken Terry.

Eddy DM.

Med Econ. 1997 Apr 28;74(9):67-70. No abstract available.

PMID:
10166723
31.
32.
33.

Health system reform. Will controlling costs require rationing services?

Eddy DM.

JAMA. 1994 Jul 27;272(4):324-8. No abstract available.

PMID:
7888005
34.

A piece of my mind. A conversation with my mother.

Eddy DM.

JAMA. 1994 Jul 20;272(3):179-81. No abstract available.

PMID:
8022025
35.
36.

Importance of professional nursing values: a national study of baccalaureate programs.

Eddy DM, Elfrink V, Weis D, Schank MJ.

J Nurs Educ. 1994 Jun;33(6):257-62.

PMID:
8046517
37.

Clinical decision making: from theory to practice. Three battles to watch in the 1990s.

Eddy DM.

JAMA. 1993 Jul 28;270(4):520-6. No abstract available.

PMID:
8320794
38.

Medicine by numbers.

Eddy DM.

Lancet. 1993 Jun 12;341(8859):1540-1. No abstract available.

PMID:
8099417
39.
40.
41.

High-dose chemotherapy with autologous bone marrow transplantation for metastatic breast cancer.

Eddy DM, Hillner BE, Smith TJ, Desch CE.

JAMA. 1992 Sep 23-30;268(12):1536-7. No abstract available.

PMID:
1518100
43.
44.

Medicine, money, and mathematics.

Eddy DM.

Bull Am Coll Surg. 1992 Jun;77(6):36-49. No abstract available.

PMID:
10118543
45.

Synthesis of environmental evidence: nitrogen dioxide epidemiology studies.

Hasselblad V, Eddy DM, Kotchmar DJ.

J Air Waste Manage Assoc. 1992 May;42(5):662-71. Review.

PMID:
1627322
46.

High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.

Eddy DM.

J Clin Oncol. 1992 Apr;10(4):657-70. Review. Erratum in: J Clin Oncol 1992 Oct;10(10):1655-8.

PMID:
1285731
47.
48.

Oregon's plan. Should it be approved?

Eddy DM.

JAMA. 1991 Nov 6;266(17):2439-45. No abstract available.

PMID:
1920751
49.

Oregon's methods. Did cost-effectiveness analysis fail?

Eddy DM.

JAMA. 1991 Oct 16;266(15):2135-41. No abstract available.

PMID:
1920704
50.

Clinical decision making: from theory to practice. What's going on in Oregon?

Eddy DM.

JAMA. 1991 Jul 17;266(3):417-20. No abstract available.

PMID:
2056654

Supplemental Content

Support Center